We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » More Detail to Be Made Public on FDA Advisory Panel Finances
More Detail to Be Made Public on FDA Advisory Panel Finances
April 23, 2010
The FDA is proposing to disclose a new detail in listing conflicts of interest for advisory committee members — the name of the company or institution involved — as the agency’s head recommends that officials minimize conflicts of interest on panels.